Quidelortho
QuidelOrtho Corporation is an American multinational diagnostic healthcare enterprise headquartered in San Diego, California. The company specializes in the development, manufacturing, and commercialization of rapid diagnostic immunoassays, molecular testing platforms, clinical chemistry systems, and transfusion medicine products utilized in hospitals, clinical laboratories, blood banks, and physician offices globally. Principal revenue is derived through wholesale manufacturing sales of diagnostic testing instruments, reagent kits, and consumable test supplies. QuidelOrtho Corporation is publicly listed on the Nasdaq Stock Market.
2 of the funds FundTelligence covers report a position in Quidelortho.
- Legal name
- QUIDELORTHO CORP
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 2
Funds holding Quidelortho
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.07 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)